Metabolic syndrome in childhood leukemia survivors: a meta-analysis

Endocrine

Volumn 49, Issue 2, 2015, Pages 353-360

  Faienza, Maria Felicia ^a   Delvecchio, Maurizio ^b   Giordano, Paola ^a   Cavallo, Luciano ^a   Grano, Maria ^a   Brunetti, Giacomina ^a   Ventura, Annamaria ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Chemotherapy; Childhood leukemia survivors; Meta analysis; Metabolic syndrome; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOMETABOLIC RISK; CASE CONTROL STUDY; CHILDHOOD LEUKEMIA; DIET; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFECT; EVALUATION STUDY; HUMAN; LIFESTYLE; META ANALYSIS; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; THERAPY EFFECT; ADULT; ADVERSE EFFECTS; CHEMORADIOTHERAPY; CHILD; COMPLICATION; LEUKEMIA; STATISTICS AND NUMERICAL DATA; SURVIVOR;

ADULT; CHEMORADIOTHERAPY; CHILD; HUMANS; LEUKEMIA; METABOLIC SYNDROME X; SURVIVORS;

EID: 84943014542     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0395-7     Document Type: Article

References (50)

1. C.H. Pui, L.L. Robison, A.T. Look, Acute lymphoblastic leukemia. Lancet 371, 1030–1043 (2008)
2. A. Jemal, R. Siegel, J. Xu, E. Ward, Cancer statistics, 2010. CA Cancer J. Clin. 60, 277–300 (2010)
3. Scottish Intercollegiate Guidelines Network (SIGN), Long term follow up of survivors of childhood cancer (SIGN, Edinburgh, 2013). SIGN publication no. 132
4. L.L. Robison, S. Bhatia, Late-effects among survivors of leukaemia and lymphoma during childhood and adolescence. Br. J. Haematol. 122, 345–359 (2003)
5. K.C. Oeffinger, A.C. Mertens, C.A. Sklar, T. Kawashima, M.M. Hudson, A.T. Meadows, D.L. Friedman, N. Marina, W. Hobbie, N.S. Kadan-Lottick, C.L. Schwartz, W. Leisenring, L.L. Robison, Childhood Cancer Survivor Study: chronic health conditions in adult survivors of childhood cancer. N. Engl. J. Med. 355, 1572–1582 (2006)
6. R. Mody, S. Li, D.C. Dover, S. Sallan, W. Leisenring, K.C. Oeffinger, Y. Yasui, L.L. Robison, J.P. Neglia, Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood 111, 5515–5523 (2008)
7. M.J. Harila, S. Winqvist, M. Lanning, R. Bloigu, A.H. Harila-Saari, Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia. Pediatr. Blood Cancer 53, 156–161 (2009)
8. K.H. Darzy, S.M. Shalet, Hypopituitarism following radiotherapy revisited. Endocr Dev. 15, 1–24 (2009)
9. L. Iughetti, P. Bruzzi, B. Predieri, P. Paolucci, Obesity in patients with acute lymphoblastic leukemia in childhood. Ital J Pediatr. 38, 4 (2012). doi:10.1186/1824-7288-38-4
10. N.J. van Casteren, G.H. van der Linden, F.G. Hakvoort-Cammel, K. Hählen, G.R. Dohle, M.M. van den Heuvel-Eibrink, Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr. Blood Cancer 52, 108–112 (2009)
11. C. Eiser, Beyond survival: quality of life and follow-up after childhood cancer. J. Pediatr. Psychol. 32, 1140–1150 (2007)
12. M. Delvecchio, V. Cecinati, L.P. Brescia, M.F. Faienza, D. De Mattia, L. Cavallo, N. Santoro, Thyroid function and thyroid autoimmunity in childhood acute lymphoblastic leukemia off-therapy patients treated only with chemotherapy. J. Endocrinol. Invest. 33, 135–139 (2010)
13. K.C. Oeffinger, G.R. Buchanan, D.A. Eshelman, M.A. Denke, T.C. Andrews, J.A. Germak, G.E. Tomlinson, L.E. Snell, B.M. Foster, Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematolol Oncol. 23, 424–430 (2001)
14. K. Link, C. Moëll, S. Garwicz, E. Cavallin-Ståhl, J. Björk, U. Thilén, B. Ahrén, E.M. Erfurth, Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J. Clin. Endocrinol. Metab. 89, 5003–5012 (2004)
15. J.G. Gurney, K.K. Ness, S.D. Sibley, M. O’Leary, D.R. Dengel, J.M. Lee, N.M. Youngren, S.P. Glasser, K.S. Baker, Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 107, 1303–1312 (2006)
16. P.M. Janiszewski, K.C. Oeffinger, T.S. Church, A.L. Dunn, D.A. Eshelman, R.G. Victor, S. Brooks, A.J. Turoff, E. Sinclair, J.C. Murray, L. Bashore, R. Ross, Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J. Clin. Endocrinol. Metab. 92, 3816–3821 (2007)
17. B.I. Razzouk, S.R. Rose, S. Hongeng, D. Wallace, M.P. Smeltzer, M. Zacher, C.H. Pui, M.M. Hudson, Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. J. Clin. Oncol. 25, 1183–1189 (2007)
18. G. Trimis, M. Moschovi, I. Papassotiriou, G. Chrousos, F. Tzortzatou-Stathopoulou, Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J. Pediatr. Hematol. Oncol. 29, 309–314 (2007)
19. M. Jarfelt, B. Lannering, I. Bosaeus, G. Johannsson, R. Bjarnason, Body composition in young adult survivors of childhood acute lymphoblastic leukemia. Eur. J. Endocrinol. 153, 81–89 (2005)
20. M. Kourti, A. Tragiannidis, A. Makedou, T. Papageorgiou, I. Rousso, F. Athanassiadou, Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J. Pediatr. Hematol. Oncol. 27, 499–501 (2005)
21. N. Reisi, A. Azhir, M. Hashemipour, P. Raeissi, A. Amini, A. Moafi, The metabolic syndrome in survivors of childhood acute lymphoblastic leukemia in Isfahan. Iran. J Res Med Sci. 14, 111–116 (2009)
22. C. Follin, U. Thilén, B. Ahrén, E.M. Erfurth, Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J. Clin. Endocrinol. Metab. 91, 1872–1875 (2006)
23. E.J. Chow, J.H. Simmons, C.L. Roth, K.S. Baker, P.A. Hoffmeister, J.E. Sanders, D.L. Friedman, Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood Marrow Transplant. 16, 1674–1681 (2010)
24. C. Oudin, M.C. Simeoni, N. Sirvent, A. Contet, Begu-Le Coroller, A., Bordigoni, P., Curtillet, C., Poirée, M., Thuret, I., Play, B., Massot, M.C., Chastagner, P., Chambost, H., Auquier, P., Michel, G.: prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood 117, 4442–4448 (2011)
25. H. Karakurt, N. Sarper, S.Ç. Kılıç, S.A. Gelen, E. Zengin, Screening survivors of childhood acute lymphoblastic leukemia for obesity, metabolic syndrome, and insulin resistance. Pediatr. Hematol. Oncol. 29, 551–561 (2012)
26. F. Aldhafiri, A. Al-Nasser, A. Al-Sugair, H. Al-Mutairi, D. Young, J.J. Reilly, Obesity and metabolic syndrome in adolescent survivors of standard risk childhood acute lymphoblastic leukemia in Saudi Arabia. Pediatr. Blood Cancer 59, 133–137 (2012)
27. K. Blijdorp, M. van Waas, A.J. van der Lely, R. Pieters, M. van den Heuvel-Eibrink, S. Neggers, Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia. Leuk. Res. 37, 367–371 (2013)
28. K.K. Ness, W. Leisenring, P. Goodman, T. Kawashima, A.C. Mertens, K.C. Oeffinger, G.T. Armstrong, L.L. Robison, Assessment of selection bias in clinic-based populations of childhood cancer survivors: a report from the childhood cancer survivor study. Pediatr. Blood Cancer 52, 379–386 (2009)
29. K.A. Nottage, K.K. Ness, C. Li, D. Srivastava, L.L. Robison, M.M. Hudson, Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukemia - From the St. Jude Lifetime Cohort. Br J Haematol. 165, 364–374 (2014)
30. L. Ramphal, J. Zhang, S. Suzuki, Ethnic disparities in the prevalence of the metabolic syndrome in American adults: data from the Examination of National Health and Nutrition Examination Survey 1999-2010. Proc (Bayl Univ Med Cent). 27, 92–95 (2014)
31. J.P. Higgins, S.G. Thompson, Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–1558 (2002)
32. K.C. Oeffinger, A.C. Mertens, C.A. Sklar, Y. Yasui, T. Fears, M. Stovall, T.A. Vik, P.D. Inskip, L.L. Robison, Childhood Cancer Survivor Study: obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 21, 1359–1365 (2003)
33. K.A. Neville, R.J. Cohn, K.S. Steinbeck, K. Johnston, J.L. Walker, Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. J. Clin. Endocrinol. Metab. 91, 4401–4407 (2006)
34. M. Taskinen, U.M. Saarinen-Pihkala, L. Hovi, M. Lipsanen-Nyman, Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 356, 993–997 (2000)
35. S. Pietilä, A. Mäkipernaa, H. Sievänen, A.M. Koivisto, T. Wigren, H.L. Lenko, Obesity and metabolic changes are common in young childhood brain tumor survivors. Pediatr. Blood Cancer 52, 853–859 (2009)
36. J.G. Gurney, K.K. Ness, M. Stovall, S. Wolden, J.A. Punyko, J.P. Neglia, A.C. Mertens, R.J. Packer, L.L. Robison, C.A. Sklar, Final height and body mass index among adult survivors of childhood brain cancer: childhood cancer survivor study. J. Clin. Endocrinol. Metab. 88, 4731–4739 (2003)
37. E.I. Mayer, M. Reuter, R.E. Dopfer, M.B. Ranke, Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm. Res. 53, 193–199 (2000)
38. B.M. Brennan, A. Rahim, W.F. Blum, J.A. Adams, O.B. Eden, S.M. Shalet, Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity? Clin Endocrinol (Oxf). 50, 163–169 (1999)
39. K. He, K. Liu, M.L. Daviglus, S.J. Morris, C.M. Loria, L. Van Horn, D.R. Jacobs Jr, P.J. Savage, Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 113, 1675–1682 (2006)
40. H. Lajer, H. Bundgaard, N.H. Secher, H.H. Hansen, K. Kjeldsen, G. Daugaard, Severe intracellular magnesium and potassium depletion in patients after treatment with cisplatin. Br. J. Cancer 89, 1633–1637 (2003)
41. J. Nuver, A.J. Smit, J. van Der Meer, M.P. van Den Berg, W.T. van der Graaf, M.T. Meinardi, D.T. Sleijfer, H.J. Hoekstra, A.I. van Gessel, A.M. van Roon, J.A. Gietema, Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol 23, 9130–9137 (2005)
42. J.A. Kim, M. Montagnani, K.K. Koh, M.J. Quon, Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113, 1888–1904 (2006)
43. K.K. Ness, M.M. Hudson, J.P. Ginsberg, R. Nagarajan, S.C. Kaste, N. Marina, J. Whitton, L.L. Robison, J.G. Gurney, Physical performance limitations in the Childhood Cancer Survivor Study cohort. J. Clin. Oncol. 27, 2382–2389 (2009)
44. D.R. Herman, P.A. Ganz, L. Petersen, G.A. Greendale, Obesity and cardiovascular risk factors in younger breast cancer survivors: the cancer and menopause study (CAMS). Breast Cancer Res. Treat. 93, 13–23 (2005)
45. K.S. Baker, K.K. Ness, J. Steinberger, A. Carter, L. Francisco, L.J. Burns, C. Sklar, S. Forman, D. Weisdorf, J.G. Gurney, S. Bhatia, Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 109, 1765–1772 (2007)
46. A. Tichelli, S. Bhatia, G. Socié, Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br. J. Haematol. 142, 11–26 (2008)
47. L.R. Meacham, E.J. Chow, K.K. Ness, K.Y. Kamdar, Y. Chen, Y. Yasui, K.C. Oeffinger, C.A. Sklar, L.L. Robison, A.C. Mertens, Cardiovascular risk factors in adult survivors of pediatric cancer–a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 19, 170–181 (2010)
48. M. Steffens, V. Beauloye, B. Brichard, A. Robert, O. Alexopoulou, Ch. Vermylen, D. Maiter, Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL). Clin Endocrinol (Oxf). 69, 819–827 (2008)
49. M. van Waas, S.J. Neggers, A.J. van der Lelij, R. Pieters, M.M. van den Heuvel-Eibrink, The metabolic syndrome in adult survivors of childhood cancer, a review. J. Pediatr. Hematol. Oncol. 32, 171–179 (2010)
50. C.M. Brownstein, A.C. Mertens, P.A. Mitby, M. Stovall, J. Qin, G. Heller, L.L. Robison, C.A. Sklar, Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 89, 4422–4427 (2004)